A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer

NCT04809142 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

392

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Biliary Cancer

Interventions

DRUG: TQB2450 Injection
DRUG: Anlotinib hydrochloride
DRUG: Oxaliplatin injection
DRUG: Capecitabine tablets
DRUG: Gemcitabine hydrochloride injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.